Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Dicyandiamide Market Estimated to Reach US$ 535 Mn by 2025; Demand for Anti-diabetic Drugs is Increasing Across the Globe: Transparency Market Research

This image opens in the lightbox

News provided by

Transparency Market Research

13 Apr, 2018, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

ALBANY, New York, April 13, 2018 /PRNewswire/ --

The global dicyandiamide market was valued at around US$ 260.2 Mn in 2017 and is anticipated to expand at a CAGR of over 8.5% from 2018 to 2026, according to a new report by Transparency Market Research (TMR) titled 'Dicyandiamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026.' Dicyandiamide is a dimer of cyandiamide. Dicyandiamide is also known as 2-Cyanoguanidine. The major benefits of dicyandiamide (DCD) are that it is extremely reactive and non-hazardous, due to which it is used for a variety of applications. Dicyandiamide is primarily of three grades: electronic, industrial, and pharmaceutical. Some companies have developed ultra-micronized grade and other grades. All these grades are employed as an intermediate in various applications such pharmaceuticals, epoxy laminates, flame retardants, slow release fertilizers, water treatment, dye fixing, and many others.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Request A Sample Of Dicyandiamide Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42551

Rise in Demand for Metformin from the Rising Diabetic Population across the Globe Likely to Drive the Market for Dicyandiamide during the Forecast Period 

Type-II diabetes is one of the most common diseases across the globe. Type II diabetes accounts for more than 90% of all cases of diabetes. Diabetes is one of the major causes of death in most countries. Dicyandiamide is primarily used in the manufacture of metformin, a preferred drug for the treatment of type II diabetes. Asia Pacific is one of the key metformin producing and exporting regions across the globe. Hence, rising demand for dicyandiamide in these regions is expected to drive the market during the forecast period. Dicyandiamide is also used as intermediate in the production of flame retardants, fertilizers, coatings, adhesives, melamine, etc. However, various cost-effective and better-performing substitutes to dicyandiamide are available. Previously, dicyandiamide was predominantly used for production of melamine, but now the production of melamine from dicyandiamide is replaced with urea. Availability of substitutes for dicyandiamide is anticipated to hamper the overall demand for dicyandiamide during the forecast period. Dicyandiamide producing companies with well-established R&D facilities have developed ultra-micronized grade dicyandiamide, which is used for various applications such as epoxy powder coating, electronic potting, film adhesives, etc. This type of grade is effective compared to electronic and industrial grade and is non-toxic. The ultra-micronized grade is estimated to provide lucrative opportunities during the forecast period as it offers superior adhesion properties compared to other grades.

Get PDF Brochure for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42551

Pharmaceutical and Industrial are the Major Grade Types for the Dicyandiamide Market 

In terms of product, the pharmaceutical grade is a major segment of the dicyandiamide market and is expected to dominate the market during the forecast period in terms of value and volume. Pharmaceutical grade is primarily utilized for producing anti-diabetic drugs. Industrial grade is another major grade type after pharmaceutical, which is used in various applications. Prominent applications include dye fixing, flame retardants, as nitrogen stabilizer in fertilizers, etc. Due to this, industrial grade segment is expected to expand at a significant pace after pharmaceuticals.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42551

Growth of Pharmaceutical Industry in Asia Pacific Anticipated to Drive the Dicyandiamide Market in the Region 

In terms of revenue and volume, Asia Pacific held a significant share of more than 50% of the global dicyandiamide market in 2017. Asia Pacific countries, especially China and India, are focusing on pharmaceutical industries, which is a major driver of demand for dicyandiamide. India and China are leading countries in terms of number of diabetic patients. There is a need to develop anti-diabetic drugs to treat this disease. As dicyandiamide is used in production of anti-diabetic drugs, the demand for this product is expected to increase during the forecast period. Other end-user industries such as electronics, textile, agricultural fertilizer where dicyanamide is used as a curing agent for epoxy resins, dye fixing, and nitrogen stabilizer, respectively, are also expanding at a significant pace in Asia Pacific. This is driving demand for dicyandiamide in the region.

Ask for Discount on Premium Research Report (US$ 5795) With Complete TOC: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42551

Consolidated Market for Dicyandiamide with very Few Countries Producing and Exporting to All Regions 

The global dicyandiamide market is highly consolidated with major manufacturing players located in China. Some of the major players include AlzChem Group AG, Ningxia Darong Industry Group Co., Ltd., Ningxia Jiafeng Chemicals Co., Ltd., Ningxia Yinglite Chemical Co., Ltd., Ningxia Blue-White-Black Activated Carbon Co. Ltd., Ningxia Sunnyfield Chemical Co. Ltd., and Shizuishan Pengsheng Chemical Co., Ltd. AlzChem Group AG is the only company that has a dicyandiamide manufacturing facility outside Asia. AlzChem Group AG has capacity of 20,000 tons per annum, which is the highest worldwide. Majority of the dicyandiamide market is import based where end-user industries procure dicyandiamide either directly through manufacturers based in China and Germany or through traders or importers located in the respective region. Chinese players do not sell their products under any brand names. However, AlzChem Group AG sell its products under brand names such as Dyhard, Tropharm, etc.

Dicyandiamide Market: by Grade 

  • Electronic Grade
  • Industrial Grade
  • Pharmaceutical Grade
  • Others

Dicyandiamide Market: by Application 

  • Pharmaceuticals
  • Epoxy Laminates
  • Slow-release Fertilizers
  • Flame Retardants
  • Dye Fixing
  • Water Treatment
  • Others (gun powder, air bags, paper sizing, etc.)

Popular Research Reports of TMR: 

  • Truck Mounted Concrete Pump Market: https://www.transparencymarketresearch.com/mena-truck-mounted-concrete-pump-market.html
  • Brake oil Aftermarket for Off-highway vehicles: https://www.transparencymarketresearch.com/brake-oil-aftermarket-off-highway-vehicles.html

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Research Blog: https://cmfenews.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.